Journal article
Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels
Authors
Mithoowani S; Moffat KA; Gupta A; Carlino SA; Crowther MA
Journal
Thrombosis Research, Vol. 215, , pp. 1–4
Publisher
Elsevier
Publication Date
July 1, 2022
DOI
10.1016/j.thromres.2022.05.005
ISSN
0049-3848